Rating History for Krystal Biotech (KRYS) by Goldman Sachs
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/20/2023 | Andrea Tan | New Coverage | Buy (N/A) |
160.00 (N/A) |
98.34 (163.97) |
66.74% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 11/20/2023 | Andrea Tan | New Coverage | Buy (N/A) |
160.00 (N/A) |
98.34 (163.97) |
66.74% | Details |
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
